A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder
about
Differentiating bipolar disorder-not otherwise specified and severe mood dysregulationThe Status of Irritability in Psychiatry: A Conceptual and Quantitative ReviewThe aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake.Serotonergic contribution to boys' behavioral regulationEffects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study.Serotonin selectively influences moral judgment and behavior through effects on harm aversion.Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.Impulse control disorders: updated review of clinical characteristics and pharmacological management.Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits.Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects.Gender differences in aggression of borderline personality disorderImpulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 DisordersANXIOUS AND AGGRESSIVE: THE CO-OCCURRENCE OF IED WITH ANXIETY DISORDERS.Lifetime history of cigarette smoking associated with aggression and impulsivity in both healthy and personality disordered volunteers.Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorderImpact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.Pharmacological management of acute and persistent aggression in forensic psychiatry settings.The appropriateness of treating psychopathic disorders.Serotonin and impulsive aggression.White Matter Integrity Reductions in Intermittent Explosive Disorder.Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor.Social Learning Requires Plasticity Enhanced by Fluoxetine Through Prefrontal Bdnf-TrkB Signaling to Limit Aggression Induced by Post-Weaning Social Isolation.Social cognition in Intermittent Explosive Disorder and aggression.Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people.Relationship between psychopathy, aggression, anger, impulsivity, and intermittent explosive disorder.Neurocircuitry of aggression and aggression seeking behavior: nose poking into brain circuitry controlling aggression.Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement
P2860
Q22252416-F49CCD00-50DC-46BA-9C26-7BC9EEF0EDC4Q26747136-5C5B77F2-E714-4815-B4F4-FA54E8F39849Q28391257-8248882B-28DE-4F10-B044-A7AB7A58DB4BQ28744067-63C9C5B0-8BE2-4419-BB07-4FF38897C9FAQ30830264-BDD62FAF-A71E-4D6C-AD9C-D600B7B7289DQ34140426-663EDB90-0869-4474-95E7-9FDFC0791697Q34152823-3DCE0806-453D-46B9-AEEB-49C2B6600759Q34660742-C06969E5-C882-4C99-B452-F9E019B5CC23Q34953189-FED4C306-1EB8-4FEF-B531-5A493C63FE2AQ34963939-65F89379-4EC5-4D7F-ADD9-E49BAC4FFFBFQ35058108-F5DAB703-75FB-40B3-ADE5-0E4050E217C8Q35965869-176628F6-9824-4A55-B559-41FB6935F2C8Q36084750-000A17B2-49DC-4815-99A3-7A7E8A3637E8Q36415996-1909D5AC-5962-4983-8D4A-0F6FD71FC6E9Q36510246-AA503510-BAB7-4F29-AF4B-172A93E46DF2Q36676813-359E3FC5-BEE6-4095-9C10-602BCE3E9D4BQ36815653-FEEE6F5C-9749-4428-BBE6-19BD89560C28Q37130105-43C7D932-A8D8-4548-A96C-DFD9E9ACD48CQ37693269-70129018-7297-4A7B-A187-70CCC227AB22Q37963568-D86BE390-16CC-48CB-A3A8-86B5125D78CCQ38439581-905ACE39-D1B9-497D-B94D-DB4A9B6EB1A4Q38495637-2ACC1775-0507-4522-BC8D-B51CF8FACF36Q41654814-EE4BBB26-D32F-4FDC-A2C6-37597B1F40ECQ42681553-ACB84DE1-7DD3-497B-A1D5-FE918660AEE1Q47138284-6F5F0186-101F-4E90-B427-71E485A1EC62Q47162899-E9E897A0-5F7A-407C-A6E2-9EC6089933A2Q47586182-8AB90D81-57C8-422B-9294-4755E6E4FCDBQ47884620-19573937-3D5C-47AC-9B02-A0B49109CAE7Q52663003-E929F5FE-3CA2-4B7E-B59B-A9178B42879CQ58392040-0852F9BA-5E90-4D6B-AB73-1D8BE541A23C
P2860
A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A double-blind, randomized, pl ...... ntermittent explosive disorder
@ast
A double-blind, randomized, pl ...... ntermittent explosive disorder
@en
A double-blind, randomized, pl ...... ntermittent explosive disorder
@nl
type
label
A double-blind, randomized, pl ...... ntermittent explosive disorder
@ast
A double-blind, randomized, pl ...... ntermittent explosive disorder
@en
A double-blind, randomized, pl ...... ntermittent explosive disorder
@nl
prefLabel
A double-blind, randomized, pl ...... ntermittent explosive disorder
@ast
A double-blind, randomized, pl ...... ntermittent explosive disorder
@en
A double-blind, randomized, pl ...... ntermittent explosive disorder
@nl
P2093
P3181
P356
P1476
A double-blind, randomized, pl ...... ntermittent explosive disorder
@en
P2093
Emil F Coccaro
Richard J Kavoussi
Royce J Lee
P304
P3181
P356
10.4088/JCP.08M04150
P407
P577
2009-04-21T00:00:00Z